title: In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide.
authors.affiliation: Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, France. annakyla@hotmail.com
authors.forename: Anna D
authors.initials: AD
authors.lastname: Petropoulou
authors.forename: Grigoris T
authors.initials: GT
authors.lastname: Gerotziafas
authors.forename: Meyer M
authors.initials: MM
authors.lastname: Samama
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hatmi
authors.forename: Francine
authors.initials: F
authors.lastname: Rendu
authors.forename: Ismail
authors.initials: I
authors.lastname: Elalamy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001777:Blood Coagulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects*; D013917:Thrombin / Q000096:biosynthesis*; D018180:Thrombomodulin / Q000097:blood*
chemical_list: D018180:Thrombomodulin; D013792:Thalidomide; D013917:Thrombin